Revenue - Basilea Pharmaceutica AG (SIX:BSLN) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 40.7 CHF 1.24%

Updated:

Basilea Pharmaceutica AG
Revenue

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

|

Adjust for Inflation

Basilea Pharmaceutica AG
Revenue Peer Comparison

ADCT

ACIU

CRSP

IDIA

KURN

Company		Revenue	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Basilea Pharmaceutica AG SIX:BSLN	Revenue CHf157.6m	CAGR 3-Years 7%	CAGR 5-Years 4%	CAGR 10-Years 14%
	ADC Therapeutics SA NYSE:ADCT	Revenue $69.6m	CAGR 3-Years N/A	CAGR 5-Years 129%	CAGR 10-Years N/A
	AC Immune SA NASDAQ:ACIU	Revenue CHf14.8m	CAGR 3-Years -1%	CAGR 5-Years 16%	CAGR 10-Years N/A
	CRISPR Therapeutics AG NASDAQ:CRSP	Revenue $371.2m	CAGR 3-Years 709%	CAGR 5-Years 160%	CAGR 10-Years N/A
	Idorsia Ltd SIX:IDIA	Revenue CHf97.1m	CAGR 3-Years 60%	CAGR 5-Years -9%	CAGR 10-Years N/A
	Kuros Biosciences AG SIX:KURN	Revenue CHf33.6m	CAGR 3-Years 103%	CAGR 5-Years 116%	CAGR 10-Years N/A

See Also

Based on the financial report for Dec 31, 2023, Basilea Pharmaceutica AG's Revenue amounts to 157.6m CHF.

Over the last year, the Revenue growth was 7%. The average annual Revenue growth rates for Basilea Pharmaceutica AG have been 7% over the past three years , 4% over the past five years , and 14% over the past ten years .

Join more than 135,200+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.